UK Companies House feature
GLAXO OPERATIONS UK LIMITED
Profile
- Company number
- 00711851
- Status
- Active
- Incorporation
- 1962-01-01
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have taken into account that as part of the Group, the Company has already received the necessary letter of support from GlaxoSmithKline Finance plc and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “Turnover was £825,617,000 for the year ended 31 December 2024 (2023: £659,082,000). The increase is mainly due to an increase in tolling charge income, restructuring cost income and other site manufacturing income during the year. Operating profit for the year ended 31 December 2024 was £39,933,000 (2023: £28,427,000). The Company made a profit for the financial year of £13,877,000 (2023: £7,131,000). The increase in profit is mainly due to a significant increase in turnover during the year.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 43 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WHYTE, Victoria Anne | Secretary | 1998-12-18 | — | British |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2006-08-31 | — | — |
| OLIINYK, Dmytro | Director | 2022-02-19 | Jun 1983 | Ukrainian |
| SPEAR, Paul Andrew | Director | 2020-08-25 | Jun 1974 | British |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2024-07-08 | — | — |
Show 43 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BICKNELL, Simon Michael | Secretary | 1994-11-24 | 1998-12-18 |
| CHRISTIAN, Christopher Lindsay | Secretary | — | 1994-11-24 |
| STEPHENS, Richard James | Secretary | 2003-07-21 | 2007-03-05 |
| ADCOCK, Matthew Creighton | Director | 2013-04-09 | 2014-07-01 |
| BAKER, Christopher, Dr | Director | — | 1993-05-23 |
| BAXTER, Jeffrey Royston | Director | 1997-05-02 | 2001-12-19 |
| BELL, Alan Menzies, Dr | Director | 1999-01-01 | 2001-12-30 |
| BLAKER, Graham Joseph, Dr | Director | — | 1998-06-01 |
| BRUCE, Paul Lawrence | Director | 1997-09-15 | 1998-12-18 |
| BURNS, Alan George | Director | 2017-05-05 | 2019-05-08 |
| CALDWELL, Joseph, Dr | Director | 1997-01-20 | 1998-08-19 |
| CALLIANO, Riccardo | Director | 2014-07-21 | 2017-10-01 |
| CARDWELL, Ian | Director | 2010-02-23 | 2011-12-31 |
| CARTMELL, Simon Christopher | Director | 1993-06-01 | 1995-01-01 |
| CHALLONER, Stanley Clive | Director | — | 1994-01-31 |
| ELLIOT, John Bell | Director | 2003-05-14 | 2006-12-31 |
| HEPBURN, Stuart | Director | 2012-01-04 | 2016-05-01 |
| HIGHAM, John Stanley | Director | — | 1993-03-03 |
| HUMER, Franz Bernhard | Director | — | 1993-05-12 |
| JONES, David John | Director | 2003-05-14 | 2009-05-07 |
| JONGEN, Freek | Director | 2017-10-01 | 2020-08-25 |
| JORDAN, Stephen | Director | 2003-05-14 | 2010-02-23 |
| KELLER, Philip Henry | Director | 1997-08-02 | 1997-09-12 |
| KENNEDY, James | Director | — | 1993-02-01 |
| LATCHFORD, Richard John | Director | 2021-05-07 | 2022-02-19 |
| MCCUBBIN, Ian | Director | 2013-07-05 | 2017-03-31 |
| MCINNES, Ian Alexander Thomson, Dr | Director | 1993-03-03 | 1996-10-11 |
| MILLER, Timothy John | Director | 1999-01-01 | 2000-06-02 |
| MULLINS, Sheila | Director | 2019-03-22 | 2020-08-25 |
| O'HARA, Neil | Director | 2010-02-23 | 2013-04-09 |
| PADFIELD, John Malcolm, Doctor | Director | — | 1994-03-31 |
| PARKES, Philip Edward | Director | — | 1993-08-31 |
| PATTESON-BRENT, Erika | Director | 2020-08-25 | 2021-09-29 |
| POWER, Joseph James | Director | 2019-03-22 | 2020-12-31 |
| PRICE, Barry John, Dr | Director | 1995-01-01 | 1995-12-31 |
| PULMAN, David, Doctor | Director | 1997-01-24 | 2003-05-14 |
| READSHAW, Ashley | Director | 1993-09-01 | 1997-01-17 |
| REYNAUD, Jean Paul | Director | 2003-05-14 | 2013-07-12 |
| SIMARD, Regis Jean-Pierre | Director | 2016-05-18 | 2019-05-02 |
| TYSON, Timothy Cyril | Director | 1998-06-01 | 2002-12-01 |
| VITTY, Graham John | Director | — | 1994-11-03 |
| WAIGHTS, Christopher Charles Bolingbroke | Director | 1994-04-13 | 1995-01-01 |
| GLAXO GROUP LIMITED | Corporate Director | 2002-09-11 | 2003-07-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Glaxo Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 267 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-08-15 | AA | accounts | accounts with accounts type full |
| 2025-08-04 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-23 | CH03 | officers | change person secretary company with change date |
| 2024-09-22 | AA | accounts | accounts with accounts type full |
| 2024-09-17 | CH01 | officers | change person director company with change date |
| 2024-09-17 | CH01 | officers | change person director company with change date |
| 2024-09-11 | AD01 | address | change registered office address company with date old address new address |
| 2024-08-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-07-18 | AD02 | address | change sail address company with old address new address |
| 2024-07-08 | AP02 | officers | appoint corporate director company with name date |
| 2024-02-20 | RESOLUTIONS | resolution | resolution |
| 2024-02-20 | MA | incorporation | memorandum articles |
| 2024-02-15 | CC04 | change-of-constitution | statement of companys objects |
| 2023-08-22 | AA | accounts | accounts with accounts type full |
| 2023-08-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-16 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2022-10-13 | AA | accounts | accounts with accounts type full |
| 2022-08-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-03-10 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.